检索结果 - Su Pin Choo

Refine Results
  1. 1
    Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond

    Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond 由 Yun Hua Lee, David Tai, Connie Yip, Su Pin Choo, Valerie Chew

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma

    Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma 由 Ann‐Lii Cheng, Chiun Hsu, Stephen L. Chan, Su Pin Choo, Masatoshi Kudo

    出版 2020
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Comparison of hepatocellular carcinoma in <scp>E</scp>astern versus <scp>W</scp>estern populations

    Comparison of hepatocellular carcinoma in <scp>E</scp>astern versus <scp>W</scp>estern populations 由 Su Pin Choo, Wan Ling Tan, Brian K. P. Goh, Wai Meng David Tai, Andrew X. Zhu

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma

    RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma 由 Hung Huynh, Pierce K. H. Chow, Khee Chee Soo, Han Chong Toh, Su Pin Choo, Kian Fong Foo, Donald Poon, Van Chanh Ngo, Evelyn Tran

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90

    A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90 由 Jin‐Yao Teo, John Carson Allen, David Ng, Su Pin Choo, David Tai, Pik‐Eu Chang, Foong-Khoon Cheah, Pierce K. H. Chow, Brian K. P. Goh

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

    Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma 由 Hung Huynh, Van Chanh Ngo, Heng Nung Koong, Donald Poon, Su Pin Choo, Choon Hua Thng, Pierce K. H. Chow, Hock Soo Ong, Alexander Yaw Fui Chung, Khee Chee Soo

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence

    Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evid... 由 Ye Xin Koh, Hwee Leong Tan, Weng Kit Lye, Juinn Huar Kam, Adrian Kah Heng Chiow, Siong San Tan, Su Pin Choo, Alexander Yaw Fui Chung, Brian K. P. Goh

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements

    A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements 由 Masatoshi Kudo, Kwang‐Hyub Han, Sheng-Long Ye, Jian Zhou, Yi‐Hsiang Huang, Shi-Ming Lin, Chung-Kwe Wang, Masafumi Ikeda, Stephen L. Chan, Su Pin Choo, Shiro Miyayama, Ann‐Lii Cheng

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma

    Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma 由 Kennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, Desiree Shu Hui Tay, Ailica Wan Xin Lee, Andrea Jing Shi Ang, Lawrence Wen Jun Wong, Su Pin Choo, David Tai, Joycelyn Jie Xin Lee

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

    Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis 由 Thomas Yau, Chiun Hsu, Tae‐You Kim, Su Pin Choo, Yoon‐Koo Kang, Ming‐Mo Hou, Kazushi Numata, Winnie Yeo, Akhil Chopra, Masafumi Ikeda, Ryoko Kuromatsu, Michihisa Moriguchi, Yee Chao, Huanyu Zhao, Jeffrey Anderson, Christine Dela Cruz, Masatoshi Kudo

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma

    Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma 由 Pierce K. H. Chow, Donald Poon, Khin Maung Win, Harjit Singh, Ho‐Seong Han, Anthony Goh, Su Pin Choo, Hee-Kit Lai, Richard Hoau Gong Lo, Kiang‐Hiong Tay, T.W. Lim, Mihir Gandhi, Say‐Beng Tan, Khee‐Chee Soo

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040

    Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040 由 Anthony B. El-Khoueiry, Jörg Trojan, Tim Meyer, Thomas Yau, Ignacio Melero, Masatoshi Kudo, Chih‐Hung Hsu, T.-Y. Kim, Su Pin Choo, Yubin Kang, Winnie Yeo, Akhil Chopra, Samira Soleymani, J. Yao, Jaclyn Neely, Marina Tschaika, Theodore H. Welling, Bruno Sangro

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer

    A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer 由 Allen Lee Cohn, Josep Tabernero, Joan Maurel, Elżbieta Nowara, Javier Sastre, Benjamin Chuah, М. В. Копп, Dina Sakaeva, Edith P. Mitchell, S. Dubey, Samuel Suzuki, Y.J. Hei, Francesco Galimi, Ian McCaffery, Yang Pan, Robert D. Loberg, Susan Cottrell, Su Pin Choo

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

    A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC) 由 Wai Meng David Tai, Wei Peng Yong, Cindy Lim, Lauren Low, Chee Kian Tham, Tong San Koh, Quan Sing Ng, W.W. Wang, L.Z. Wang, Septian Hartano, Choon Hua Thng, Hung Huynh, Kok-Hing Lim, Han Chong Toh, Boon Cher Goh, Su Pin Choo

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma

    Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma 由 Sarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, Cedric Chuan Young Ng, Jason Yongsheng Chan, Vikneswari Rajasegaran, Tse Hui Lim, Kiat Hon Lim, Su Pin Choo, Simona Dima, Irinel Popescu, Dan G. Duda, Veerapol Kukongviriyapan, Narong Khuntikeo, Chawalit Pairojkul, Steve Rozen, Patrick Tan, Bin Tean Teh

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    LBA-3 CheckMate 459: Long-term (minimum follow-up 33.6 months) survival outcomes with nivolumab versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma

    LBA-3 CheckMate 459: Long-term (minimum follow-up 33.6 months) survival outcomes with nivolumab versus sorafenib as first-line treatment in patients with advanced hepatocellular ca... 由 Bruno Sangro, J. Park, Richard S. Finn, Ann‐Lii Cheng, Philippe Mathurin, Julien Edeline, Masatoshi Kudo, Kwang‐Hyub Han, James J. Harding, Philippe Merle, Olivier Rosmorduc, Lucjan Wyrwicz, E. Schott, Su Pin Choo, Robin Kate Kelley, Damir Begic, G. Chen, Jaclyn Neely, Marina Tschaika, Thomas Yau

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

    CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcino... 由 Thomas Yau, J.W. Park, Richard S. Finn, Ann‐Lii Cheng, Philippe Mathurin, Julien Edeline, Masatoshi Kudo, Kwang‐Hyub Han, James J. Harding, Philippe Merle, Olivier Rosmorduc, Lucjan Wyrwicz, E. Schott, Su Pin Choo, Robin Kate Kelley, Damir Begic, G. Chen, Jaclyn Neely, Jeffrey Anderson, Bruno Sangro

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

    A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma 由 Shukui Qin, Stephen L. Chan, Wattana Sukeepaisarnjaroen, Guohong Han, Su Pin Choo, Virote Sriuranpong, Hongming Pan, Thomas Yau, Yabing Guo, Minshan Chen, Zhenggang Ren, Jianming Xu, Chia-Jui Yen, Zhong-Zhe Lin, Luigi Manenti, Yi Gu, Yongjian Sun, Ralph Tiedt, Lu Hao, Wenjie Song, Tawesak Tanwandee

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma

    The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma 由 Soo Fan Ang, Elizabeth Shu-Hui Ng, Huihua Li, Ariel Yuhan Ong, Su Pin Choo, Joanne Ngeow, Han Chong Toh, Kiat Hon Lim, Hao Yun Yap, Chee‐Kiat Tan, London Lucien Ooi, Alexander Yaw Fui Chung, Pierce K. H. Chow, Kian Fong Foo, Min‐Han Tan, Peng Chung Cheow

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery

    Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery 由 Sarah B. Ng, Clarinda Chua, Matthew Chau Hsien Ng, Anna Gan, Polly Poon, Melissa Ching Ching Teo, Cherylin Fu, Wei Qiang Leow, Kiat Hon Lim, Alexander Yaw Fui Chung, Si‐Lin Koo, Su Pin Choo, Danliang Ho, Steve Rozen, Patrick Tan, Mark Wong, William F. Burkholder, Iain Beehuat Tan

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: